Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 30 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 38,497 followers.

RT @GarbineLizeaga: Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis https://t.co/FL7qCuo8Ey

12 Aug 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis: Myasthenia gravis (MG) is an aut…

12 Aug 2021

Reply Repost Favourite

New Research: Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis: Myasthenia gravis (MG) is an autoimmune disease primarily mediated by acetylcholine receptor antibodies (AChR-Ab), cellular immune dependence, and… https://t.co/lGjP7n

11 Aug 2021

Reply Repost Favourite

Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis https://t.co/FL7qCuo8Ey

11 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.